BioArctic AB (publ) (BRCTF)
OTCMKTS
· Delayed Price · Currency is USD
19.00
+0.52 (2.81%)
Apr 23, 2025, 3:09 PM EDT
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
$217,321
Profits / Employee
-$149,534
Market Cap
1.70B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Northwest Biotherapeutics | 25 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
BioArctic AB News
- 23 days ago - The European Commission refers lecanemab decision to Appeal Committee - PRNewsWire
- 4 weeks ago - BioArctic's partner Eisai presents sales simulation for Leqembi® at its annual press conference - PRNewsWire
- 5 weeks ago - BioArctic receives Orphan Drug Designation for exidavnemab the US - PRNewsWire
- 7 weeks ago - Therapeutic Goods Administration decides not to register lecanemab in Australia - PRNewsWire
- 7 weeks ago - The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU - PRNewsWire
- 2 months ago - Leqembi® sales reaches €200 million - first sales milestone achieved - PRNewsWire
- 3 months ago - FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US - Benzinga
- 3 months ago - FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US - PRNewsWire